TROVAGENE, INC. $30,000,000 of Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • January 25th, 2013 • TrovaGene Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 25th, 2013 Company Industry JurisdictionTrovagene, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: